Initial partial response and stable disease according to RECIST indicate similar survival for chemotherapeutical patients with advanced non-small cell lung cancer

BACKGROUND: Stable disease (SD) has ambiguous clinical significance for patients according to the dominant Response Evaluation Criteria in Solid Tumours (RECIST). The primary aims of the study were: (1) to clarify the clinical significance of SD by comparing the progression-free survival (PFS) of re...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Lijie, Teng, Yuee, Jin, Bo, Zhao, Mingfang, Yu, Ping, Hu, Xuejun, Zhang, Jingdong, Li, Songbai, Gao, Yaling, Liu, Yunpeng
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3018460/
https://www.ncbi.nlm.nih.gov/pubmed/21156055
http://dx.doi.org/10.1186/1471-2407-10-681

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3018460/
https://www.ncbi.nlm.nih.gov/pubmed/21156055
http://dx.doi.org/10.1186/1471-2407-10-681

Ejemplares similares